Product | Code | Size | Price € | | Preventivo / Ordina |
(-)-6-AZAURIDINE 2’, 3’,5’-TRIACETATE
Alternative Names: 2',3',5'-Tri-O-acetyl-6-azauridine; Azaribine; 6-AzUrd-TA
|
BVN-B1025-250
| 250 mg |
inquire
|
|
|
(-)-6-AZAURIDINE 2’, 3’,5’-TRIACETATE
Alternative Names: 2',3',5'-Tri-O-acetyl-6-azauridine; Azaribine; 6-AzUrd-TA
|
BVN-B1025-50
| 50 mg |
inquire
|
|
|
(-)-ARCTIGENIN
Alternative Names: (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one,Arctigenin
|
BVN-B2786-10
| 10 mg |
inquire
|
|
|
(-)-ARCTIGENIN
Alternative Names: (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one,Arctigenin
|
BVN-B2786-50
| 50 mg |
inquire
|
|
|
(-)-BLEBBISTATIN
Alternative Names: 1,2,3,3a-tetrahydro-3aS-hydroxy-6-methyl-1-phenyl-4H-Pyrrolo[2,3-b]quinolin-4-one; (S)-Blebbistatin
|
BVN-2406-1
| 1 mg |
inquire
|
|
|
(-)-BLEBBISTATIN
Alternative Names: 1,2,3,3a-tetrahydro-3aS-hydroxy-6-methyl-1-phenyl-4H-Pyrrolo[2,3-b]quinolin-4-one; (S)-Blebbistatin
|
BVN-2406-5
| 5 mg |
inquire
|
|
|
(-)-DEGUELIN
Alternative Names: (7aS,13aS)-13,13a-Dihydro-9,10-dimethoxy-3,3-dimethyl-3H-bis[1]benzopyrano[3,4-b:6′,5′-e]pyran-7(7aH)-one
|
BVN-B2096-25
| 25 mg |
inquire
|
|
|
(-)-DEGUELIN
Alternative Names: (7aS,13aS)-13,13a-Dihydro-9,10-dimethoxy-3,3-dimethyl-3H-bis[1]benzopyrano[3,4-b:6′,5′-e]pyran-7(7aH)-one
|
BVN-B2096-5
| 5 mg |
inquire
|
|
|
(-)-EPIGALLOCATECHIN GALLATE
Alternative Names: EGCG; (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate)
|
BVN-1841-50
| 50 mg |
inquire
|
|
|
(-)-EQUOL
Alternative Names: (3S)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol; (S)-Equol; 4',7-Isoflavandiol; 4',7-Dihydroxyisoflavan; (S)-3,4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol
|
BVN-B3081-25
| 25 mg |
inquire
|
|
|
(-)-EQUOL
Alternative Names: (3S)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol; (S)-Equol; 4',7-Isoflavandiol; 4',7-Dihydroxyisoflavan; (S)-3,4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol
|
BVN-B3081-5
| 5 mg |
inquire
|
|
|
(−)-HUPERZINE A
|
BVN-B3095-25
| 25 mg |
inquire
|
|
|
(−)-HUPERZINE A
|
BVN-B3095-5
| 5 mg |
inquire
|
|
|
(-)-INDOLACTAM V
Alternative Names: (2S,5S)-1,2,4,5,6,8-Hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one
|
BVN-2197-1000
| 1 mg |
inquire
|
|
|
(-)-INDOLACTAM V
Alternative Names: (2S,5S)-1,2,4,5,6,8-Hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one
|
BVN-2197-250
| 250 µg |
inquire
|
|
|
(-)-JQ1
Alternative Names: t-Butyl-2-((6R)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
|
BVN-2384-1
| 1 mg |
inquire
|
|
|
(-)-MK 801 HYDROGEN MALEATE
Alternative Names: (5R,10S)-(-)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d]cylcohepten-5,10-imine maleate
|
BVN-B2327-25
| 25 mg |
inquire
|
|
|
(-)-MK 801 HYDROGEN MALEATE
Alternative Names: (5R,10S)-(-)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d]cylcohepten-5,10-imine maleate
|
BVN-B2327-5
| 5 mg |
inquire
|
|
|
(-)-P-BROMOTETRAMISOLE OXALATE
Alternative Names: (-)-p-Bromolevamisole oxalate; 6-Bromolevamisole oxalate, S(−)-6-(4-Bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole oxalate
|
BVN-1901-25
| 25 mg |
inquire
|
|
|
(-)-P-BROMOTETRAMISOLE OXALATE
Alternative Names: (-)-p-Bromolevamisole oxalate; 6-Bromolevamisole oxalate, S(−)-6-(4-Bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole oxalate
|
BVN-1901-5
| 5 mg |
inquire
|
|
|
(-)-QUINPIROLE HYDROCHLORIDE
Alternative Names: (4aR,8aR)-5-propyl-1,4,4a,6,7,8,8a,9-octahydropyrazolo[3,4-g]quinoline,hydrochloride; (4aR-trans)-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H-pyrazolo[3,4-g]quinoline hydrochloride; LY 171555; Dopamine D₂ Receptor Agonist
|
BVN-B2994-25
| 25 mg |
inquire
|
|
|
(-)-QUINPIROLE HYDROCHLORIDE
Alternative Names: (4aR,8aR)-5-propyl-1,4,4a,6,7,8,8a,9-octahydropyrazolo[3,4-g]quinoline,hydrochloride; (4aR-trans)-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H-pyrazolo[3,4-g]quinoline hydrochloride; LY 171555; Dopamine D₂ Receptor Agonist
|
BVN-B2994-5
| 5 mg |
inquire
|
|
|
(+)-ABSCISIC ACID
Alternative Names: 5-[(1S)-1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-2Z,4E-pentadienoic acid; ABA; Dormin
|
BVN-2543-1
| 1 mg |
inquire
|
|
|
(+)-ABSCISIC ACID
Alternative Names: 5-[(1S)-1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-2Z,4E-pentadienoic acid; ABA; Dormin
|
BVN-2543-5
| 5 mg |
inquire
|
|
|
(+-)-BAY K 8644
Alternative Names: 1,4-Dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl) phenyl]-3-pyridinecarboxylic acid, methyl ester
|
BVN-1682-5
| 5 mg |
inquire
|
|
|
(+)-BLEBBISTATIN
Alternative Names: 1,2,3,3a-tetrahydro-3aR-hydroxy-6-methyl-1-phenyl-4H-Pyrrolo[2,3-b]quinolin-4-one; (R)-Blebbistatin
|
BVN-2407-1
| 1 mg |
inquire
|
|
|
(+)-BLEBBISTATIN
Alternative Names: 1,2,3,3a-tetrahydro-3aR-hydroxy-6-methyl-1-phenyl-4H-Pyrrolo[2,3-b]quinolin-4-one; (R)-Blebbistatin
|
BVN-2407-5
| 5 mg |
inquire
|
|
|
(+)-CIS-DILTIAZEM HYDROCHLORIDE
Alternative Names: CRD-401, (2S,3S)-(+)-cis-3-Acetoxy-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one hydrochloride
|
BVN-B2557-1G
| 1 g |
inquire
|
|
|
(+)-CIS-DILTIAZEM HYDROCHLORIDE
Alternative Names: CRD-401, (2S,3S)-(+)-cis-3-Acetoxy-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one hydrochloride
|
BVN-B2557-5G
| 5 g |
inquire
|
|
|
EZSOLUTION™ (+)-JQ1
Alternative Names: t-Butyl-2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
|
BVN-2091-1
| 1 mg |
inquire
|
|
|
(+)-MK 801 HYDROGEN MALEATE
Alternative Names: 10,11-dihydro-5S-methyl-5H-dibenzo[a,d]cyclohepten-5,10-imine, (2Z)-2-butenedioate,Dizocilpine
|
BVN-B2326-25
| 25 mg |
inquire
|
|
|
(+)-MK 801 HYDROGEN MALEATE
Alternative Names: 10,11-dihydro-5S-methyl-5H-dibenzo[a,d]cyclohepten-5,10-imine, (2Z)-2-butenedioate,Dizocilpine
|
BVN-B2326-5
| 5 mg |
inquire
|
|
|
(±)-BLEBBISTATIN
Alternative Names: (±)-1,2,3,3a-tetrahydro-3a-hydroxy-6-methyl-1-phenyl-4H-pyrrolo[2,3-b]quinolin-4-one
|
BVN-2405-25
| 25 mg |
inquire
|
|
|
(±)-BLEBBISTATIN
Alternative Names: (±)-1,2,3,3a-tetrahydro-3a-hydroxy-6-methyl-1-phenyl-4H-pyrrolo[2,3-b]quinolin-4-one
|
BVN-2405-5
| 5 mg |
inquire
|
|
|
(±)-GOSSYPOL
Alternative Names: (±)-2,2′-bis(8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene; NSC 56817; NSC 524336; BL 193; Pogosin
|
BVN-2579-250
| 250 mg |
inquire
|
|
|
(±)-GOSSYPOL
Alternative Names: (±)-2,2′-bis(8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene; NSC 56817; NSC 524336; BL 193; Pogosin
|
BVN-2579-50
| 50 mg |
inquire
|
|
|
(±)-THALIDOMIDE
Alternative Names: (RS)-2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione
|
BVN-2020-10
| 10 mg |
inquire
|
|
|
(±)-THALIDOMIDE
Alternative Names: (RS)-2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione
|
BVN-2020-50
| 50 mg |
inquire
|
|
|
(±)-Β-HYDROXYBUTYRATE
Alternative Names: 3-hydroxybutyric acid; 3-hydroxybutanoic acid; DL-beta-Hydroxybutyric acid; 3-oxidanylbutanoic acid; NSC 3806
|
BVN-B2829-100
| 100 mg |
inquire
|
|
|
(±)-Β-HYDROXYBUTYRATE
Alternative Names: 3-hydroxybutyric acid; 3-hydroxybutanoic acid; DL-beta-Hydroxybutyric acid; 3-oxidanylbutanoic acid; NSC 3806
|
BVN-B2829-500
| 500 mg |
inquire
|
|
|
(E/Z)-4-HYDROXYTAMOXIFEN
Alternative Names: 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-phenol; Afimoxifene; 4-OHT Purity: ≥98% (E) and (Z) isomers (50:50)
|
BVN-B2030-25
| 25 mg |
inquire
|
|
|
(E/Z)-4-HYDROXYTAMOXIFEN
Alternative Names: 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-phenol; Afimoxifene; 4-OHT Purity: ≥98% (E) and (Z) isomers (50:50)
|
BVN-B2030-5
| 5 mg |
inquire
|
|
|
(R)-(+)-ETOMOXIR
Alternative Names: (R)-2-[6-(4-Chlorophenoxy)hexyl]oxiranecarboxylic acid, ethyl ester
|
BVN-B1104-1
| 1 mg |
inquire
|
|
|
(R)-(+)-ETOMOXIR
Alternative Names: (R)-2-[6-(4-Chlorophenoxy)hexyl]oxiranecarboxylic acid, ethyl ester
|
BVN-B1104-5
| 5 mg |
inquire
|
|
|
(R)-BICALUTAMIDE
Alternative Names: (2R)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
|
BVN-B2173-25
| 25 mg |
inquire
|
|
|
(R)-BICALUTAMIDE
Alternative Names: (2R)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
|
BVN-B2173-5
| 5 mg |
inquire
|
|
|
(R,R)-HYMEGLUSIN
Alternative Names: (2E,4E,7R)-11-[(2R,3R)-3-(Hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid
|
BVN-B1244-1000
| 1 mg |
inquire
|
|
|
(R,R)-HYMEGLUSIN
Alternative Names: (2E,4E,7R)-11-[(2R,3R)-3-(Hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid
|
BVN-B1244-500
| 500 µg |
inquire
|
|
|
(R,S)-LENALIDOMIDE
Alternative Names: (R,S)-3-(4-amino-1-oxo-3H-isoindol-2-yl)piperidine-2,6-dione
|
BVN-1862-100
| 100 mg |
inquire
|
|
|
(R,S)-LENALIDOMIDE
Alternative Names: (R,S)-3-(4-amino-1-oxo-3H-isoindol-2-yl)piperidine-2,6-dione
|
BVN-1862-25
| 25 mg |
inquire
|
|
|